Central veins of the chest: Evaluation with time-resolved MR angiography

Radiology

Volumn 247, Issue 2, 2008, Pages 558-566

  Kim, Charles Y ^a   Mirza, Rizvan A ^a   Bryant, Joshua A ^a   Whiting, Eric D ^a   Delong, David M ^a   Spritzer, Charles E ^a   Merkle, Elmar M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CENTRAL VEIN; CLINICAL ARTICLE; FEMALE; HUMAN; INFORMED CONSENT; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MEDICAL ASSESSMENT; PHLEBOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STENOSIS; VEIN OCCLUSION; ANALYSIS OF VARIANCE; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; STENOSIS, OCCLUSION AND OBSTRUCTION; THORAX; VASCULAR DISEASE; VASCULARIZATION;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CONSTRICTION, PATHOLOGIC; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PHLEBOGRAPHY; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; THORAX; VASCULAR DISEASES;

EID: 44449160410     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2472070790     Document Type: Article

References (30)

1. Johnsrude IS. Venography and lymphangiography. In: Johnsrude IS, Jackson DC, Dunnick NR, eds. A practical approach to angiography. 2nd ed. Boston, Mass: Little, Brown, 1987;565-650.
2. Nael K, Laub G, Finn JP. Three-dimensional contrast-enhanced MR angiography of the thoraco-abdominal vessels. Magn Reson Imaging Clin N Am 2005;13(2):359-380.
3. Thornton MJ, Ryan R, Varghese JC, Farrell MA, Lucey B, Lee MJ. A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins. AJR Am J Roentgenol 1999;173:999-1003.
4. Tanju S, Sancak T, Dusunceli E, Yagmurlu B, Erden I, Sanlidilek U. Direct contrast-enhanced 3D MR venography evaluation of upper extremity deep venous system. Diagn Interv Radiol 2006;12:74-79.
5. Shinde TS, Lee VS, Rofsky NM, Krinsky GA, Weinreb JC. Three-dimensional gadolinium-enhanced MR venographic evaluation of patency of central veins in the thorax: initial experience. Radiology 1999;213:555-560.
6. Oxtoby JW, Widjaja E, Gibson KM, Uzoka K. 3D gadolinium-enhanced MRI venography: evaluation of central chest veins and impact on patient management. Clin Radiol 2001;56:887-894.
7. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243(1):148-157.
8. Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007;188:586-592.
9. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242(3):647-649.
10. High WA, Ayers RA, Chandler J, Zito G, Cowper SE. Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 2007;56(1):21-26.
11. Marckmann P, Skoy L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17(9):2359-2362.
12. Korosec FR, Frayne R, Grist TM, Mistretta CA. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996;36(3):345-351.
13. Du J, Thornton FJ, Mistretta CA, Grist TM. Dynamic MR venography: an intrinsic benefit of time-resolved MR angiography. J Magn Reson Imaging 2006;24:922-927.
14. Pinto C, Hickey R, Carroll TJ, et al. Time-resolved MR angiography with generalized autocalibrating partially parallel acquisition and time-resolved echo-sharing angiographic technique for hemodialysis arteriovenous fistulas and grafts. J Vasc Interv Radiol 2006;17(6):1003-1009.
15. Michaely HJ, Herrmann KA, Dietrich O, Reiser MF, Schoenberg SO. Quantitative and qualitative characterization of vascularization and hemodynamics in head and neck tumors with a 3D magnetic resonance time-resolved echo-shared angiographic technique (TREAT): initial results. Eur Radiol 2007;17(4):1101-1110.
16. Michaely HJ, Nael K, Schoenberg SO, et al. Renal perfusion: comparison of saturation-recovery TurboFLASH measurements at 1.5T with saturation-recovery TurboFLASH and time-resolved echo-shared angiographic technique (TREAT) at 3.0T. J Magn Reson Imaging 2006;24(6):1413-1419.
17. Brauck K, Maderwald S, Vogt FM, Zenge M, Barkhausen J, Herborn CU. Time-resolved contrast-enhanced magnetic resonance angiography of the hand with parallel imaging and view sharing: initial experience. Eur Radiol 2007;17(1):183-192.
18. Fink C, Puderbach M, Ley S, Zaporozhan J, Plathow C, Kauczor HU. Time-resolved echoshared parallel MRA of the lung: observer preference study of image quality in comparison with non-echo-shared sequences. Eur Radiol 2005;15(10):2070-2074.
19. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174.
20. Masunaga H, Takehara Y, Isoda H, et al. Assessment of gadolinium-enhanced time-resolved three-dimensional MR angiography for evaluating renal artery stenosis. AJR Am J Roentgenol 2001;176:1213-1219.
21. Froger CL, Duijm LE, Liem YS, et al. Stenosis detection with MR angiography and digital subtraction angiography in dysfunctional hemodialysis access fistulas and grafts. Radiology 2005;234:284-291.
22. Zhang HL, Khilnani NM, Prince MR, et al. Diagnostic accuracy of time-resolved 2D projection MR angiography for symptomatic infrapopliteal arterial occlusive disease. AJR Am J Roentgenol 2005;184:938-947.
23. Swan JS, Carroll TJ, Kennell TW, et al. Time-resolved three dimensional contrast-enhanced MR angiography of the peripheral vessels. Radiology 2002;225(1):43-52.
24. Lee VS, Martin DJ, Krinsky GA, Rofsky NM. Gadolinium-enhanced MR angiography: artifacts and pitfalls. AJR Am J Roentgenol 2000;175:197-205.
25. Lee YJ, Chung TS, Joo JY, Chien D, Laub G. Suboptimal contrast-enhanced carotid MR angiography from the left brachiocephalic venous stasis. J Magn Reson Imaging 1999;10:503-509.
26. Public health advisory: update on magnetic resonance imaging (MRI) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy. U.S. Food and Drug Administration Web site. http://www.fda.gov/cder/drug/advisory/ gadolinium-agents-20061222.htm. Published December 22, 2006. Accessed May 3, 2007.
27. MacRae JM, Ahmed A, Johnson N, Levin A, Kiaii M. Central vein stenosis: a common problem in patients on hemodialysis. ASAIO J 2005;51(1):77-81.
28. Willinek WA, Bayer T, Gieseke J, et al. High spatial resolution contrast-enhanced MR angiography of the supraaortic arteries using the quadrature body coil at 3.0T: a feasibility study. Eur Radiol 2007;17(3):618-625.
29. Frydrychowicz A, Bley TA, Winterer JT, et al. Accelerated time-resolved 3D contrast-enhanced MR angiography at 3T: clinical experience in 31 patients. MAGMA 2006;19(4):187-195.
30. Cashen TA, Carr JC, Shin W, et al. Intracranial time-resolved contrast-enhanced MR angiography at 3T. AJNR Am J Neuroradiol 2006;27(4):822-829.